Arrowhead Pharmaceuticals Inc (ARWR)
Return on total capital
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 83,079 | -75,072 | -89,248 | -600,255 | -580,108 | -525,685 | -455,027 | -282,542 | -188,165 | -168,267 | -142,088 | -150,455 | -174,831 | -155,884 | -115,706 | -188,304 | -149,037 | -134,273 | -118,351 | -112,359 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 466,052 | 519,806 | 683,321 | 52,589 | 185,444 | 330,547 | 483,794 | 160,407 | 271,343 | 364,830 | 446,772 | 377,039 | 105,960 | 453,927 | 452,266 | 372,560 | 408,822 | 436,890 | 445,549 | 454,472 |
| Return on total capital | 17.83% | -14.44% | -13.06% | -1,141.41% | -312.82% | -159.03% | -94.05% | -176.14% | -69.35% | -46.12% | -31.80% | -39.90% | -165.00% | -34.34% | -25.58% | -50.54% | -36.46% | -30.73% | -26.56% | -24.72% |
September 30, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $83,079K ÷ ($—K + $466,052K)
= 17.83%